Vistagen Therapeutics, Inc. (VTGN) Q1 2025 Earnings Call Transcript
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) Q1 2025 Earnings Convention Name August 13, 2024 5:00 PM ET Firm Individuals Mark McPartland - ...
Tag: Therapeutics
Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript
Heron Therapeutics, Inc., (NASDAQ:HRTX) Q2 2024 Earnings Convention Name August 6, 2024 4:30 PM ET Company Contributors Craig Collard - ...
Viking Therapeutics: Potential Winner In Competitive Obesity Drug Race (NASDAQ:VKTX)
Sasha Brazhnik/iStock by way of Getty Photographs The burden loss drug sector is seeing an more and more intensified drug ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics By Investing.com
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a number one nationwide securities regulation agency, is ...
Sarepta Therapeutics surges 32% on expanded FDA approval for Duchenne gene therapy By Investing.com
Investing.com - Sarepta Therapeutics (NASDAQ:), a pioneer in precision genetic drugs for uncommon illnesses, surged in Thursday's after-hours offers after ...
Applied Therapeutics: Navigating Challenges In ARI Development
Klaus Vedfelt Govorestat’s Race Towards Galactose: A Candy or Bitter Future? Utilized Therapeutics (NASDAQ:APLT) is a clinical-stage biotech firm growing ...
Buying Esperion Therapeutics Despite An Abiding Skepticism Weighing On The Stock (ESPR)
Ariel Skelley/DigitalVision through Getty Pictures President and CEO of Esperion Therapeutics, Inc. (NASDAQ:ESPR), Sheldon Koenig, promised that the corporate would ...
Check Out What Whales Are Doing With VKTX – Viking Therapeutics (NASDAQ:VKTX)
Whales with some huge cash to spend have taken a noticeably bullish stance on Viking Therapeutics. choices historical past for ...
Akari Therapeutics secures $1.6M in private placement By Investing.com
© Reuters. In a strategic transfer, Akari Therapeutics (NASDAQ: NASDAQ:) has introduced right now a non-public placement settlement with choose ...
Aquestive Therapeutics stock target raised to $8 on FDA hopes By Investing.com
© Reuters. On Wednesday, Lake Road Capital Markets adjusted its outlook on Aquestive Therapeutics (NASDAQ:), a pharmaceutical firm, by growing ...
